Sector revisions The Carlyle Group Inc.
Equities
CG
US14316J1088
Investment Management & Fund Operators
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
52.54 USD | -0.09% |
|
-5.75% | +5.11% |
Feb. 03 | Baxter's Kidney Care Segment Vantive Acquired by Carlyle Group | MT |
Jan. 31 | Shareholder activists demand clear strategy from thyssenkrupp CEO | RE |
1m. Revenue rev. | 4m. EPS revision | 4m. Revenue rev. | 1y. EPS revision | 1y. Revenue rev. | Visibility | Nbr of analysts | ||
---|---|---|---|---|---|---|---|---|
18 | ||||||||
19 | ||||||||
20 | ||||||||
14 | ||||||||
15 | ||||||||
16 | ||||||||
15 | ||||||||
14 | ||||||||
25 | ||||||||
7 | ||||||||
- | 1 | |||||||
- | 2 | |||||||
2 | ||||||||
14 | ||||||||
10 | ||||||||
4 | ||||||||
6 | ||||||||
20 | ||||||||
7 | ||||||||
3 | ||||||||
Average | 12 | |||||||
Weighted average by Cap. | 17 |
- Stock Market
- Equities
- CG Stock
- Sector The Carlyle Group Inc.
- Sector revisions